+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study



Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study



Journal of the European Academy of Dermatology and Venereology 21(3): 345-350



Background: Recently, two placebo-controlled studies have shown that topical metronidazole was effective in the treatment of seborrheic dermatitis. Objective: To compare the efficacy and safety of metronidazole 0.75% gel with that of ketoconazole 2% cream in the treatment of facial seborrheic dermatitis. Methods: A total of 60 consecutive patients with facial seborrheic dermatitis were included. Patients were randomized into two groups.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 013059793

Download citation: RISBibTeXText

PMID: 17309456

DOI: 10.1111/j.1468-3083.2006.01927.x


Related references

Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis. A double-blind comparative study. Journal of the American Academy of Dermatology 19(5 Pt 1): 850-853, 1988

Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream. Journal of the American Academy of Dermatology 12(5, part 1): 852-856, 1985

Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: A double-blind, randomized clinical trial. International Journal of Women's Dermatology 3(2): 107-110, 2017

Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. Journal of the American Academy of Dermatology 57(2): 257-264, 2007

A double blind study of the effectiveness of sertaconazole 2% cream vs. metronidazole 1% gel in the treatment of seborrheic dermatitis. Annals of Parasitology 59(4): 173-177, 2013

Double blind study of excipient versus 2 percent ketoconazole cream in the treatment of seborrheic dermatitis of the infant. Annales de Dermatologie et de Venereologie 122(Suppl. 1): S84-S85, 1995

A double blind trial of treatment of seborrheic dermatitis with 2 percent ketoconazole cream compared with 1 percent hydrocortisone cream. British Journal of Dermatology 121(3): 353-358, 1989

Ketoconazole 2 percent cream versus hydrocortisone 1 percent cream in the treatment of seborrheic dermatitis a double blind comparative study. Journal of the American Academy of Dermatology 19(5 Part 1): 850-853, 1988

A double blind comparison of 2 percent ketoconazole cream and 1 percent hydrocortisone cream in the treatment of seborrheic dermatitis. Current Therapeutic Research 51(5): 723-729, 1992

Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial. Archives of Dermatology 142(8): 1066-1067, 2006

A Double-Blind Placebo-Controlled Study of Ketoconazole + Desonide Gel Combination in the Treatment of Facial Seborrheic Dermatitis. Dermatology 204(4): 344-347, 2002

A double-blind placebo-controlled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis. Dermatology 204(4): 344-347, 2002

Seborrheic dermatitis: use of ketoconazole cream and shampoo. Double-blind study versus placebo. Giornale Italiano di Dermatologia e Venereologia 122(11): Lvii-Lvlx, 1987

The efficacy of 1% metronidazole gel in facial seborrheic dermatitis: a double blind study. Indian Journal of Dermatology Venereology and Leprology 72(4): 266-269, 2006

Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis. Dermatology 206(3): 233-240, 2003